HopeStage
Back to all studies
CompletedNCT00303602

Dissolving olanzapine or tablets and weight gain

About this titleRead the official source — NCT00303602
Medication studyAges 18–65Multiple countriesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 65 years.

Listed locations
Escondido and 20 more locationsSee all locations and recruitment
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2006
Recruitment status
Completed
Enrollment listed in the registry
149
Sponsor
Eli Lilly and Company
Sponsor type
Other organization
Study type
Drug
Intervention type
Drug
Study phase
Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Locations
United States, Canada, Mexico, ...
Age range
From 18 Years to 65 Years
Official registry ID
NCT00303602
Official title
Show the full official title

BMI Evaluation: Placebo and Active Comparator Trial of Olanzapine Zydis Pills Used Sublingually (PLATYPUS)

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Escondido, United States · Garden Grove, United States · National City, United States

18 more locations
  • Orange, United States
  • Atlanta, United States
  • Las Vegas, United States
  • Staten Island, United States
  • Penticton, Canada
  • Winnipeg, Canada
  • Dartmouth, Canada
  • Halifax, Canada
  • Sydney, Canada
  • Chatham, Canada
  • Greater Sudbury, Canada
  • Kingston, Canada
  • Windsor, Canada
  • Sherbrooke, Canada
  • Mexico City, Mexico
  • Amersfoort, Netherlands
  • Rotterdam, Netherlands
  • San Juan, Puerto Rico

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Eli Lilly and Company.

Did this study involve medication?

Yes. The study involved medication, including Sublingual orally disintegrating olanzapine (SODO) and Oral olanzapine.

Who was this study for?

Listed age limits: 18 years to 65 years.

Want to explore more studies?

Explore studies